Excluded from the Affordable Care Act because of politics, thousands of poor Americans grapple with the toll — physical and psychological — of being uninsured

Quick Read

A sprawling health bill expected to pass the Senate, gain President Obama’s signature and become law before the end of the year is a grab bag for industries, academic institutions and patient groups that spent oodles of time and money lobbying to advance their interests. Who wins and who loses?

Quick Read

The number of schoolchildren not vaccinated against childhood diseases in Texas is growing rapidly, which means that the state may see its first measles outbreaks in the winter or spring of 2018

Quick Read

Reshma Ramachandran and our Zackary Berger voice concerns about the impact of the 21st Century Cures Act on the FDA should it become law

Quick Read

Will Trump intervene? How will a Donald J. Trump administration handle these ethically delicate materials?

Quick Read

The Affordable Care Act transformed the medical system, expanding coverage to millions, injecting billions in tax revenue, changing insurance rules and launching ambitious experiments in quality and efficiency

Quick Read

Many people in this southwestern corner of Virginia struggle to pay for everyday needs and that includes basic health care

Quick Read

Martin Shkreli. Valeant Pharmaceuticals. Mylan. These names have become big news, but just a year ago, most Americans devoted little time and attention to the question of pharmaceutical pricing. Now, a Kaiser Health Tracking Poll released Oct. 27 suggests many people care more about the increasing prices of drugs than they do about any other aspect of health care reform

Quick Read